The pre‐incubation with anti‐TLR4 antibodies (5 μg/ml) significantly inhibited the pro‐inflammatory effects of LPS and HSP60 in both sham and CHF cardiomyocytes (Fig. 7A and B). This evidence concerns the gene TLR4 and congestive heart failure.